Skip to main content

Animations

MJFF Publications

391 - 400 of 5832 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • OPEN
    Title: Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders
    Journal Name: GeroScience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11357-024-01120-4
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-024-01610-w
    Best OA location URL:
    Citation Count: 3
  • OPEN
    Title: Parkinson’s Disease is Predominantly a Genetic Disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230376
    Citation Count: 9
  • OPEN
    Title: Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-47027-8
    Citation Count: 9
  • OPEN
    Title: [3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain
    Journal Name: Experimental Brain Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00221-024-06815-w
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: Biochemical Fractionation of Human α-Synuclein in a Drosophila Model of Synucleinopathies
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25073643
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2024.1349030
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: Reticulon 2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae091
    Citation Count: 0
  • OPEN
    Title: Interpretable discriminant analysis for functional data supported on random nonlinear domains with an application to Alzheimer’s disease
    Journal Name: Journal of the Royal Statistical Society Series B: Statistical Methodology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/jrsssb/qkae023
    Citation Count: 0
  • OPEN
    Title: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.92775
    Best OA location URL:
    Citation Count: 2
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.